About Dr.Mrinal Gounder
Dr. Mrinal Gounder, MD, is the MSKCC Physician Ambassador to India and Asia. He is an internationally recognized medical oncologist specializing in sarcomas and rare cancers. He specializes in developing new drugs in cancer with a specific focus on sarcoma, a rare and devastating cancer that affects children, adolescents, and adults. He joined MSKCC in 2008 and specializes in personalized medicine, where genetic testing of cancer is used to inform the right therapies for an individual patient. He is the principal investigator of several global clinical trials (phase I – III) evaluating promising new drugs for sarcoma and many other solid cancers. He was the global lead for the study that led to FDA approval of tazemetostat in sarcoma. His work is internationally known and has been published in the New England Journal of Medicine, Journal of Clinical Oncology, Lancet Oncology, Nature Medicine, and others. His research contributions to rare cancers were recognized as the top 10 Advances of the Year in 2018 in the field of oncology.
As the Physician Ambassador to India and Asia, he is passionate about building collaborations between MSKCC and India to improve access to patient care and collaborate on education, graduate medical training, and advancing cancer research and clinical trials globally. He is fluent in Tamil, Hindi, and English.
- Northwestern University
- Memorial Sloan Kettering Cancer Center
- Medical Oncology
Areas of Expertise
- Soft Tissue and Bone Sarcomas
- Early Drug Development (Phase I/II clinical trials) – solid tumors